Recombinant SARS-CoV-2 Spike antibody (RBD)
Quick Overview for Recombinant SARS-CoV-2 Spike antibody (RBD) (ABIN7271754)
Target
See all SARS-CoV-2 Spike AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
- 
    
- 
                                            
Binding Specificity
 - RBD
 - 
                                            
Purpose
 - Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) (MALS verified)
 - 
                                            
Specificity
 - This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain. Cross-reactivity with Spike protein RBD domain of other coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1 has not been tested.
 - 
                                            
Characteristics
 - Recombinant Antibodies produced in HEK293. The antibody is isolated from the serum of COVID-19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARS-CoV-2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and Omicron.
 - 
                                            
Immunogen
 - The antibody is isolated from the serum of COVID-19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARS-CoV-2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and Omicron.
 - 
                                            
Isotype
 - IgG3
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Powder
 - 
                                            
Storage
 - -20 °C
 - 
                                            
Storage Comment
 - -20°C
 
 - 
                                            
 - 
    
- SARS-CoV-2 Spike
 - 
                                            
Background
 - It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
 
Target
 -